Binding characteristics of [

Fluorine Radioisotopes Humans Image Interpretation, Computer-Assisted / methods Neuroimaging / methods Positron-Emission Tomography / methods Protein Isoforms / analysis Radiopharmaceuticals Tauopathies / diagnostic imaging tau Proteins / analysis
PI-2620 Tau affinity binding kinetic modelling

Journal

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
ISSN: 1559-7016
Titre abrégé: J Cereb Blood Flow Metab
Pays: United States
ID NLM: 8112566

Informations de publication

Date de publication:
11 2021
Historique:
pubmed: 29 5 2021
medline: 25 2 2022
entrez: 28 5 2021
Statut: ppublish

Résumé

The novel tau-PET tracer [

Identifiants

DOI: 10.1177/0271678X211018904 PMID: 34044665 PMC: PMC8545042
pubmed: 34044665
doi: 10.1177/0271678X211018904
pmc: PMC8545042
doi:

Substances chimiques

Fluorine Radioisotopes 0
MAPT protein, human 0
Protein Isoforms 0
Radiopharmaceuticals 0
tau Proteins 0
Fluorine-18 GZ5I74KB8G

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2957-2972

Auteurs

Mengmeng Song (M)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.

Leonie Beyer (L)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.

Lena Kaiser (L)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.

Henryk Barthel (H)

Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany.

Thilo van Eimeren (T)

Cognitive Neuroscience, Institute for Neuroscience and Medicine (INM-3), Research Centre Juelich, Juelich, Germany.
Department of Nuclear Medicine, University Hospital Cologne, Cologne, Germany.
Department of Neurology, University Hospital Cologne, Cologne, Germany.
German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Ken Marek (K)

InviCRO, LLC, Boston, MA, USA.
Molecular Neuroimaging, A Division of inviCRO, New Haven, CT, USA.

Alexander Nitschmann (A)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.

Maximilian Scheifele (M)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.

Carla Palleis (C)

Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany.

Gesine Respondek (G)

Department of Neurology, Medizinische Hochschule Hannover, Hannover, Germany.

Maike Kern (M)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.

Gloria Biechele (G)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.

Jochen Hammes (J)

Department of Nuclear Medicine, University Hospital Cologne, Cologne, Germany.

Gèrard Bischof (G)

Department of Nuclear Medicine, University Hospital Cologne, Cologne, Germany.

Michael Barbe (M)

Department of Neurology, University Hospital Cologne, Cologne, Germany.

Özgür Onur (Ö)

Department of Neurology, University Hospital Cologne, Cologne, Germany.

Frank Jessen (F)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Department of Psychiatry, University Hospital Cologne, Cologne, Germany.
Center for Memory Disorders, University Hospital Cologne, Cologne, Germany.

Dorothee Saur (D)

Department of Neurology, University of Leipzig, Leipzig, Germany.

Matthias L Schroeter (ML)

Clinic for Cognitive Neurology, University of Leipzig, Leipzig, Germany.
LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Max- Planck-Institute of Human Cognitive and Brain Sciences, Leipzig, Germany.
FTLD Consortium Germany, Ulm, Germany.

Jost-Julian Rumpf (JJ)

Department of Neurology, University of Leipzig, Leipzig, Germany.

Michael Rullmann (M)

Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany.

Andreas Schildan (A)

Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany.

Marianne Patt (M)

Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany.

Bernd Neumaier (B)

Cognitive Neuroscience, Institute for Neuroscience and Medicine (INM-3), Research Centre Juelich, Juelich, Germany.
Department of Nuclear Medicine, University Hospital Cologne, Cologne, Germany.

Olivier Barret (O)

InviCRO, LLC, Boston, MA, USA.
Molecular Neuroimaging, A Division of inviCRO, New Haven, CT, USA.
Laboratoire des Maladies Neurodégénératives, Université Paris-Saclay, CEA, CNRS, MIRCen, Fontenay-aux-Roses, France.
ORCID: 0000-0003-4247-184X

Jennifer Madonia (J)

InviCRO, LLC, Boston, MA, USA.
Molecular Neuroimaging, A Division of inviCRO, New Haven, CT, USA.

David S Russell (DS)

InviCRO, LLC, Boston, MA, USA.
Molecular Neuroimaging, A Division of inviCRO, New Haven, CT, USA.
ORCID: 0000-0002-9105-2943

Andrew W Stephens (AW)

Life Molecular Imaging GmbH, Berlin, Germany.

Andre Mueller (A)

Life Molecular Imaging GmbH, Berlin, Germany.

Sigrun Roeber (S)

Center for Neuropathology and Prion Research, University Hospital of Munich, LMU Munich, Munich, Germany.

Jochen Herms (J)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Center for Neuropathology and Prion Research, University Hospital of Munich, LMU Munich, Munich, Germany.

Kai Bötzel (K)

Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany.

Adrian Danek (A)

Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany.
ORCID: 0000-0001-8857-5383

Johannes Levin (J)

Department of Neurology, University Hospital of Munich, LMU Munich, Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Joseph Classen (J)

Department of Neurology, University of Leipzig, Leipzig, Germany.

Günter U Höglinger (GU)

Department of Neurology, Medizinische Hochschule Hannover, Hannover, Germany.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Department of Neurology, Technical University Munich, Munich, Germany.

Peter Bartenstein (P)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Victor Villemagne (V)

Department of Molecular Imaging & Therapy, Austin Health, Heidelberg, VIC, Australia.
The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, VIC, Australia.
Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VIC, Australia.

Alexander Drzezga (A)

Department of Nuclear Medicine, University Hospital Cologne, Cologne, Germany.
German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

John Seibyl (J)

InviCRO, LLC, Boston, MA, USA.
Molecular Neuroimaging, A Division of inviCRO, New Haven, CT, USA.

Osama Sabri (O)

Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany.

Guido Boening (G)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.

Sibylle Ziegler (S)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.

Matthias Brendel (M)

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
ORCID: 0000-0002-9247-2843

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Produits chimiques inorganiques › Isotopes › Radio-isotopes › Radio-isotopes du fluor › Binding characteristics of [
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Binding characteristics of [
questionsmedicales.fr › Sciences de l'information › Informatique › Informatique médicale › Applications de l'informatique médicale › Prise de décision assistée par ordinateur › Diagnostic assisté par ordinateur › Interprétation d'images assistée par ordinateur › Binding characteristics of [
questionsmedicales.fr › Techniques d'investigation › Neuroimagerie › Binding characteristics of [
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › Binding characteristics of [
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Isoformes de protéines › Binding characteristics of [
questionsmedicales.fr › Actions chimiques et utilisations › Utilisations spécialisées de produits chimiques › Produits chimiques de laboratoire › Indicateurs et réactifs › Radiopharmaceutiques › Binding characteristics of [
questionsmedicales.fr › Maladies du système nerveux › Maladies neurodégénératives › Tauopathies › Binding characteristics of [
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines de tissu nerveux › Protéines associées aux microtubules › Protéines tau › Binding characteristics of [